106. C. Peterson, C.M. Brophy, P.W. Noble, A. Panitch, C. Lander, A.D. Luber, G. Nicolson, B. Leaker, W. Bradford.  Phase 1 LPS Challenge Study Of The Safety, Tolerability, Pharmacokinetics (PK) And Pharmacodynamics Of Multi-Day Inhaled (IH) Dosing Of The MAPKAP Kinase II (MK2) Inhibitor, MMI-0100, In Subjects Who Smoke. Clinical Trials. 1(2) 2016: 3. 

105. S.V. Kushchayev, M.B. Giers, D. Hom Eng, N.L. Martirosyan, J.M. Eschbacher, M.M. Mortazavi, N. Theodore, A. Panitch, M.C. Preul. Hyaluronic acid scaffold has a neuroprotective effect in hemisection spinal cord injury. Journal of Neurosurgery: Spine. 2016: 1-11. 

104. S. Sharma, N. Vazquez-Portalatin, S. Calve, A. Panitch. Biomimetic molecules lower catabolic expression and prevent chondroitin sulfate degradation in an osteoarthritic ex vivo model. ACS biomaterials science & engineering. 2(2): 2016: 241-250.

103. M. C. Preul, S. Kushchayev, D. Eng, M. Giers, N. Martirosyan, M. Mortazavi, N. Theodore, V. Sonntag, A. Panitch. Hyaluronic Acid Hydrogel Reduces Scarring in Spinal Cord Injury. Journ. of Neurosurgery.  123(2) 2015: A508-A508.

102. A.M. Kosinski, J.M. Pothen, A. Panitch, M.P. Sivasankar. Dexamethasone Controlled Release on TGF-β1 Treated Vocal Fold Fibroblasts, Annals of Otology, Rhinology, & Laryngology. 124 (7) 2015: 572-578.

101. Y.B. Shui, B.A. Filas, C.J. Siegfried, Q. Zhang, N. Ma, A. Panitch, D.C. Beebe. Synthetic Proteoglycan Mimics Preserve Vitreous Structure and Functionin Vitro and in Vivo. Investigative Ophthalmology & Visual Science. 56(7) 2015: 5109-5109.

100. A. Kole, J. Noblet, N. Ramchandani, J. Tune, A. Panitch, M. Sturek. Collagen-binding Peptide Attenuates Catheter-Induced Coronary Vasospasm. The FASEB Journal. 29 (1 Supplement) 2015: 803.3.

99. A. Lawrence, X. Xu, M.D. Bible, S. Calve, C.P. Neu, A. Panitch. Synthesis and characterization of a lubricin mimic 9mLub) to reduce friction and adhesion on the articular cartilage surface. Biomaterials, 2015,

98. J. McMasters, A. Panitch. Prevention of collagen induced platelet binding and activation by thermosensitive nanoparticles. The American Association of Pharmaceutical Scientists Journal, 2015

97. J.R. Wodicka, N.I. Onunkwo, A.J. Wooley, A. Panitch, K.J. Otto. A cell penetrating peptide for inhibition of MAPKAP kinase 2-mediated inflammatory cytokine release following glial cell activation. World Journal of Neuroscience. 2015. DOI: 10.4236/wjns.2015.52012

96. R.S. Scott, A. Ramaswamy, K. Park, A. Panitch. Decorin mimic promotes endothelial cell health in endothelial monolayers and endothelial-smooth muscle co-cultures. Journal of Tissue Engineering and Regenerative Medicine, 2015. DOI: 10.1002/term.2035

95. N. Vazquez-Portalatin, G.J. Breur, A. Panitch, C.J. Goergen. Accuracy of ultrasound-guided intra-articular injections in guinea pig knees. Bone and Joint Research, 4(1), 2015:1-5.

94. A.M. Kosinski, M.P. Sivasankar, A. Panitch. Varying RGD concentration and cell phenotype alters the expression of extracellular matrix genes in vocal fold fibrosis. Journal of Biomedical Materials Research part A. 2015. DOI: 10.1002/jbm.a.35456

93. S. Poh, J.B. Lin, A. Panitch. Release of Anti-inflammatory peptides from thermosensitive nanoparticles with degradable cross-links suppresses pro-inflammatory cytokine production. Biomacromolecules, 16(4), 2015: 1191-1200.

92. M.F. Mohamed, M.I. Hamed, A. Panitch, M.N. Seleem. Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides. Antimicrobial agents and chemotherapy. 58(7) 2014: 4113-4122.

91. R.A. Scott, A. Panitch. PDGF-stimulated smooth muscle cell behavior inhibited by decorin mimic. 2014 40th Annual Northeast Bioengineering Conference (NEBEC). 2014: 1-2

90. K. Stuart, S. Sharma, A. Panitch. Development of an aggrecan mimic to halt osteoarthritis progression. Osteoarthritis and CartilageOsteoarthritis and Cartilage. 22, 2014: S473-S474

89. Q. Zhang, B. Filas, R. Roth, J. Heuser, N. Ma, S. Sharma, A. Panitch, D.C. Beebe, Y. Shui. Preservation of the structure of enzymatically-degraded bovine vitreous using synthetic proteoglycan mimics. Investigative Ophthalmology & visual science, 55(12), 2014: 8153-8162.

88. R. Scott, A. Panitch. Macromolecular Approaches to Prevent Thrombosis and Intimal Hyperplasia Following Percutaneous Coronary Intervention. Biomacromolecules, 2014

87. R. Scott, A. Panitch. Decorin Mimic Regulates Platelet-Derived Growth Factor and Interferon-γ Stimulation of Vascular Smooth Muscle Cell. Biomacromolecules, 15(6), 2014:2090-2103.

86. J. Brugnano, A. Panitch. Matrix Stiffness affects endocytic uptake of MK2-inhibitor peptides. PLoS One, 9(1), 2014: e84821.

85. Y.B. Shui, B. Filas, Q. Zhang, S. Sharma, A. Panitch, D. Beebe. Restoration of vitreous structure after degradation. Investigative Ophthalmology & Visual Science. 54(15) 2013: 3152-3152.

84. R.L. Bartlett, S. Sharma, A. Panitch. Cell-penetrating peptides released from thermosensitive nanoparticles suppress pro-inflammatory cytokine response by specifically targeting inflamed cartilage explants. Nanomedicine: Nanotechnology, Biology and Medicine. 9(3) 2013: 419-427.

83. D. Becker, C. Oakum, E. Reynolds, R. Cook, A. Kirkpatrick, P. Arensdorf, C. Lander, A. Panitch, C. Peterson. Aerosol Performance of Spray Dried MMI-0100 from the Microdose Inhaler for Treatment of Pulmonary Fibrosis. Jour. of Aerosol Med. and Pulmonary Drug Delivery. 26(2) 2013: A54-A54.

82. R. Vittal, A. Fisher, H. Gu, E.A. Mickler, A. Panitch, C. Lander, O.W. Cummings, G.E. Sandusky, D.S. Wilkes. Peptide-mediated Inhibition of MK2 Ameliorates Bleomycin-Induced Pulmonary Fibrosis. American journal of respiratory cell and molecular biology. 2013. 

81. R.A. Scott, J.E. Paderi, M. Sturek, A. Panitch. Decorin mimic inhibits vascular smooth muscle proliferation and migration. PLoS One, 8(11), 2013: e82456.

80. J.L. Brugnano, J. McMasters, A. Panitch. Characterization of Endocytic uptake of MK2-Inhibitor Peptides. Journal of Peptide Science, 19(10), 2013:629-638.

79. S. Sharma, A. Lee, K. Choi, K. Kim, I. Youn, A. Panitch. Biomimetic aggrecan reduces cartilage extracellular matrix from degradation and lowers catabolic activity in ex vivo and in vivo models. Macromolecular Bioscience, 13(9), 2013: 1228-1237.

78. R.A. Scott, A. Panitch. Glycosaminoglycans in Biomedicine. WIREs Nanomedince & Nanobiotechnology. 5(4), 2013: 388-398.

77. R. Vittal, A. Fisher, H. Gu, E.A. Mickler, A. Panitch, C. Lander, O.W. Cummings, D.S. Wilkes, MAPKAPK2 inhibition with MMI-0100 protects against established bleomycin-induced pulmonary fibrosis in mice. American Journal of Respiratory Cell and Molecular Biology, 49(1), 2013: 47-57.

76. R.A. Scott, K. Park, A. Panitch. Water Soluble Polymer Films for Intravascular Drug Delivery of Antithrombotic Biomolecules. European Journal of Pharmaceutics and Biopharmaceutics. 2013.

75. S. Sharma, A. Panitch, C.P. Neu. Incorporation of an Aggrecan Mimic Prevents Proteolytic Degradation of Anisotropic Cartilage Analogs. Acta Biomaterialia, 9(1), 2013: 4618-4625.

74. E.A. Mickler, A.J. Fisher, A. Panitch, C. Lander, O.W. Cummings, D.S. Wilkes, R. Vittal. Inhibition Of Mk2 Activity Protects Against Bleomycin-Injured Pulmonary Fibrosis In Mice. Am. J. Respir. Crit. Care Med. 185. 2012: 2012.

73. A. Kosinski, J. Brugnano, F. Knight, B. Seal, A. Panitch. Synthesis and Characterization of a Poly(lactic-co-glycolic acid) Core + Poly(N-isopropylacrylamide) Shell Nanoparticle System. Biomatter, 2(4), 2012: 195-201

72. R. Bartlett, S. Sharma, A. Panitch. Cell penetrating peptides released from thermosensitive nanoparticles suppress pro-inflammatory cytokine response by specifically targeting inflamed cartilage explants. Nanomedicine: Nanotechnology, Biology, and Medicine, 9(3), 2012: 419-427.

71. R. Bartlett, A. Panitch. Thermosensitive nanoparticles with pH triggered degradation and release of anti-inflammatory cell penetrating-peptides. Biomacromolecules, 13(8), 2012: 2578-2584.

70. A. Hicks, M Caplan, A Panitch, J. Sweeney. An Incubatable Direct Current Stimulation System for In Vitro Studies of Mammalian Cells. Bioresearch Open Access. 1(4), 2012: 199-203.

69. R.L. Bartlett II, M.R. Medow, A. Panitch, B. Seal. Hemocompatible poly(NIPam-MBA-AMPS) colloidal nanoparticles as carriers of anti-inflammatory cell penetrating peptides. Biomacromolecules, 13(4), 2012: 1204-1211.

68. J.C. Bernhard, A. Panitch. Synthesis and Characterization of an Aggrecan Mimic. Acta Biomaterialia. 8(4), 2012: 1543-1550.

67. A. Muto, A. Panitch, N. Kim, K. Park, P. Komalavilas, C.M. Brophy, A. Dardik. Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo. Vascular Pharmacology, 56(1-2), 2011: 47-55.

66. C.M. Rupert Perez, A. Panitch, J. Chmielewski. A collagen peptide-based physical hydrogel for cell encapsulation. Macromolecular Biosciences, 11(10), 2011: 1426-1431

65. K. O’Shaughnessey, A. Panitch, J. Woodell-May. Blood-derived anti-inflammatory protein solution blocks the effect of IL-1β on human macrophages in vitro. Inflammation Research, 60(10), 2011: 929-936.

64. K. Butterfield, A. Conovaloff, A. Panitch. Development of affinity-based delivery of NGF from a chondroitin sulfate biomaterial. Biomatter, 1(2), 2011: 174-181.

63. A. Conovaloff, A. Panitch. Characterization of a chondroitin sulfate hydrogel for nerve root regeneration. Journal of Neural Engineering, 2011, 8 056003

62. A. Conovaloff, A. Panitch. Effects of a synthetic bioactive peptide on neurite growth and nerve growth factor release in chondroitin sulfate hydrogels. Biomatter, 1(2), 2011: 165-173.

61. K. Stuart, J. Paderi, P.W. Snyder, L. Freeman, A. Panitch. Collagen-Binding Peptidoglycans Inhibit MMP Mediated Collagen Degradation and Reduce Dermal Scarring. PloS one. 6(7). 2011: e22139.

60. V. Kishore, J.E. Paderi, S. Beaudoin, A. Panitch, O. Akkus. Incorporation of a decorin biomimetic enhances the mechanical properties of electrochemically aligned collagen threads. Acta Biomterialia, 7(6), 2011: 2428-2436.

59. J.L. Brugnano, B.K. Chan, B. L Seal, A. Panitch. Cell-penetrating peptides can confer biological function: Regulation of inflammatory cytokines in human monocytes by MK2 inhibitor peptides. Journal of Controlled Release. 155(2), 2011: 128-133.

58. J.E. Paderi, K. Stuart, An. Ramaswamy, A. Panitch. Directing collagen type I assembly: Mimicking the structural role of decorin. Amer. Chem. Soc. 241, 2011.

57. B.C. Ward, S. Kavalukas, J. Brugnano, A. Barbul, A. Panitch. Peptide inhibitors of MK2 show promise for inhibition of abdominal adhesions. J. Surg. Res. 169(1), 2011: e27-e36.

56. J.E. Paderi, K. Stuart, K. Park, M. Sturek, A. Panitch. The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans. Biomaterials, 32(10), 2011: 2516-2523.

55. C.M. Rupert Perez, A. Panitch, J. Chmielewski. A collagen peptide-based physical hydrogel for cell encapsulation. Macromolecular Biosciences, 11(10), 2011: 1426-1431

54. L. Joshi, M.M. Shah, C.R. Flynn, A. Panitch. Plant-Produced Recombinant Therapeutics. Encyclopedia of Biotechnology in Agriculture and Food. 2011: 522-525

53. B.C. Ward, A. Panitch. Abdominal Adhesions: Current and Novel Therapies. Journal of Surgical Research, 165(1), 2011: 91-111.

52. B. Beier, K. Musick, A. Matsumoto, A. Panitch, E. Nauman, P. Irazoqui. Toward a continuous intravascular glucose monitoring system. Sensors. 11(1), 2010: 409-424.

51. L.B. Lopes, C. M. Brophy, C.R. Flynn, Z. Yi, B.P. Bowen, C. Smoke, B. Seal, A. Panitch, P. Komalavilas. A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model. Journal of Vascular Surgery, 52(6), 2010: 1596-1607.

50. J. Brugnano, B.C. Ward, A. Panitch. Cell Penetrating Peptides Can Exert Biological Activity: A Review. BioMolecular Concepts, 1(2), 2010: 109-116.

49. D.H. Eng, M. Caplan, M. Preul, A. Panitch. Hyaluronan Scaffolds – A Balance between Backbone Functionalization and Bioactivity. Acta Biomaterialia, 6(7), 2010: 2407-2414.

48. K.C. Butterfield, A. Conovaloff, A. Panitch. Chondroitin sulfate-binding peptides block chondroitin 6-sulfate inhibition of cortical neurite growth. Neuroscience Letters, 478(2), 2010: 82-87.

47. S. Chaterji, K. Park, A. Panitch. Scaffold-free in vitro arterial mimetics: the importance of smooth muscle-endothelium contact. Tissue Engineering, 16(6), 2010: 1901-1912.

46. K.C. Butterfield, M. Caplan, A. Panitch. Identification and Sequence Composition Characterization of Chondroitin Sulfate-Binding Peptides through Peptide Array Screening. Biochemistry, 49(7), 2010 1549-1555.

45. L.B. Lopes, E.J. Furnish, P. Komalavilas, C.R. Flynn, P. Ashby, A. Hansen, D.P. Ly, G. P. Yang, M.T. Longaker, A. Panitch, C.M. Brophy. Cell Permeant Peptide Analogues of the Small Heat Shock Protein, HSP20, Reduce TGF-β1-Induced CTGF Expression in Keloid Fibroblasts. Investigative Dermatology, 129(3), 2009: 590-598.

44. A. Conovaloff, H-W. Wang, J. Cheng, A. Panitch. Imaging Growth of Neurites in Conditioned Hydrogel by Coherent Anti-Stokes Raman Scattering Microscopy. Organogenesis, 5(4) 2009: 149-155.

43. B.C. Ward, B.L. Seal, C.M. Brophy, A. Panitch. Design of a Bioactive Cell-Penetrating, Peptide: When a Transduction Domain Does More Than Transduce. J. Peptide Sci. 15(10), 2009: 668-674 (NIHMSID 212825).

42. A. Ishwar, K.J. Jeong, A. Panitch, O. Akkus. Raman Spectroscopic Investigation of GAG-Peptide Interactions. Applied Spectroscopy, 63(6), 2009: 636-641.

41. L. Lopes, C. Flynn, P. Komalavilas, A. Panitch, C.M. Brophy, B.L. Seal. Inhibition of HSP27 Phosphorylation by a Novel Cell-permeant MAPKAP Kinase 2 Inhibitor. Biochemical and Biophysical Research Communications, 382(3), 2009: 535-539

40. J. Paderi, R. Sistiabudi, A. Ivanisevic, A. Panitch. Collagen-Binding Peptidoglycans: A Biomimetic Approach to Modulate Collagen Fibrillogenesis for Tissue Engineering Applications. Tissue Engineering, 15(10), 2009: 2991-2999.

39. K.J. Jeong, A. Panitch. The Interplay between Covalent and Physical Interactions within Environment Sensitive Hydrogel. Biomacromolecules, 10(5), 2009: 1090-1099.

38. R. Sistiabudi, J. Paderi, A. Panitch, A. Ivanisevic. Modification of Native Collagen with Cell-Adhesive Peptide to Promote RPE Cell Attachment on Bruch’s Membrane. Biotechnology and Bioengineering, 102(6), 2008: 1723-1729.

37. K. Stuart, A. Panitch. Characterization of Gels Composed of Blends of Collagen I, Collagen III, and Chondroitin Sulfate. Biomacromolecules, 10(1), 2008: 25-31.

36. K. Stuart, A. Panitch. Influence of Chondroitin Sulfate on Collagen Gel Structure and Mechanical Properties at Physiologically Relevant Levels. Biopolymers 89(10), 2008: 841-851.

35. L.B. Lopes, E.J. Furnish, P. Komalavilas, C.R. Flynn, P. Ashby, A. Hansen, D.P. Ly, G.P. Yang, M.T. Longaker, A. Panitch, C.M. Brophy. Cell Permeant Peptide Analogues of the Small Heat Shock Protein, HSP20, Reduce TGF-β1-Induced CTGF Expression in Keloid Fibroblasts. Investigative Dermatology, 129(3), 2008: 590-598.

34. J.E. Paderi, A. Panitch. Design of a Synthetic Collagen-Binding Peptidoglycan that Modulates Collagen Fibrillogenesis. Biomacromolecules, 9(9), 2008: 2562-2566.

33. K.J. Jeong, K. Butterfield, A. Panitch. A novel assay to probe heparin-peptide interactions using peptide stabilized gold nanoparticles. Langmuir, 24(16), 2008: 8794-8800.

32. S. Padalkar, J. Zhao, K.Stuart, A. Panitch, J. Rickus, L. Stanciu. Preparation of biomolecule gel matrices for electron microscopy. Ultramicroscopy, 108, 2008: 309-313.

31. P. Komalavilas, L..B. Lopes, C.R. Flynn, C. Smoke, B. Seal, A. Panitch, C.M. Brophy. Reduction of heat shock protein 27 phosphorylation inhibits the development of intimal hyperplasia. The FASEB Journal, 22, 2008: 902.6-902.6.

30. L. B. Lopes, E. Furnish, P. Komalavilas, B. L. Seal, A. Panitch, M.V.L.B. Bentley, C.M. Brophy. Enhanced skin penetration of P20 phosphopeptide using protein transduction domains. European Journal of Pharmaceutics and Biopharmaceutics, 68 (2), 2008: 441-445.

29. S. Padalkar, Y. Zhao, K. Stuart, A. Panitch, J. Rickus, L. Stanciu. Preparation of Biomolecule Gel Matrices for Electron Microscopy Ultramicroscopy. 108(4), 2007: 309-313.

28. E. Horn, M. Beaumont, A. Harvey, M. Preul, A. Panitch. Influence of Cross-Linked Hyaluronan Hydrogels on Neurite Outgrowth and Recovery from Spinal Cord Injury. Journal of Neurosurgery-Spine, 6(2), 2007: 133-40

27. P. Stice, A. Gilletti, A. Panitch, J. Muthuswamy. Thin microelectrodes reduce GFAp expression in the implant site in rodent somatosensory cortex. Journal of Neuroscience Methods, Journal of Neurological Engineering, 4, 2007: 42-53.

26. B. Seal, A. Panitch. Physical Matrices Stabilized by Enzymatically Sensitive Covalent Crosslinks. Acta Biomaterialia, 2(3) 2006: 241-251.

25. B. Seal, A. Panitch. Viscoelastic Behavior of Environmentally Sensitive Biomimetic Polymer Matrices. Macromolecules, 39(6), 2006: 2268-2274.

24. L.B. Lopes, C.M. Brophy, E. Furnish, C.R. Flynn, O. Sparks, P. Komalavilas, L. Joshi, A. Panitch, V.L.B. Bentley, Comparative Study of the Skin Penetration of Protein Transduction Domains and a Conjugated Protein. Pharmaceutical Research, 22(5) 2005: 750-7.

23. C. Dreiza, C. Brophy, P. Komalavilas, M. Pallero, J. Murphy-Ullrich, E. Furnish, L. Joshi, M. von Rechenberg, J. Ho, B. Richardson, N. Xu, Y. Zhen, J.M. Peltier, A. Panitch. Transducible Heat Shock Protein 20 (HSP20) Phosphopeptide Alters Cytoskeletal Dynamics. FASEB J 19(2) 2005: 261-3.

22. B.A. Koeneman, K. Lee, A. Singh, J. He, G.B. Raupp, A. Panitch, D.G. Capco. An Ex Vivo Method for Evaluating the Biocompatibility of Neural Electrodes in Rat Brain Slice Cultures. Journal of Neuroscience Methods, 137(2) 2004: 257-263.

21. D. J. Tessier, P. Komalavilas, B. Liu, C.K. Kent, J.S. Thresher, C.M. Dreiza, A. Panitch, L. Joshi, E. Furnish, W. Stone, R. Fowl, C.M. Brophy. Transduction of peptide analogs of the small heat shock-related protein HSP20 inhibits intimal hyperplasia. Journal of Vascular Surgery, 40(1), 2004: 206-214.

20. L. Joshi, M. M. Shah, C.R. Flynn, A. Panitch. Plant‐Produced Recombinant Therapeutics. Encyclopedia of Plant and Crop Science. 2004: 969-972.

19. L.Joshi, M.M. Shah, C. R. Flynn, A. Panitch. Post‐Translational Modifications and Recombinant Therapeutic Proteins. Encyclopedia of Plant and Crop Science. 2004: 1- 4.

18. B. Seal, A. Panitch. Physical Polymer Matrices Based on Affinity Interactions Between Peptides and Polysaccharides. Biomacromolecules, 4(6), 2003: 1572-1582.

17. P.J. Stice, A. Panitch, J. Muthuswamy. Improved viability of chronic neural implants using thin microelectrodes. IEEE. 2, 2003: 1987-1989.

16. C.R. Flynn, P. Komalavilas, D. Tessier, J. Thresher, E. Niederkofler, R.W. Nelson, A. Panitch, L. Joshi, C.M. Brophy. Transduction of biologically active motifs of the small heat shock related protein, HSP20, leads to relaxation of vascular smooth muscle. Faseb J, 17(10), 2003: 1358-60.

15. D. Tessier, P. Komalavilas, A. Panitch, L. Joshi, C.M. Brophy. The small heat shock protein, HSP20, is dynamically associated with the actin cross-linking protein, actinin. J Surg Res, 111(1), 2003: 152-157.

14. A. Panitch, B. Seal. Biologically-based self-assembling hydrogels. Amen. Chem. Soc. 224, U493-U493.

13. S. Halstenberg, A. Panitch, S. Rizzi, H. Hall, and J.A. Hubbell. Biologically Engineered Protein-graft-Poly(Ethylene Glycol) Hydrogels: A Cell-Adhesive and Plasmin-Degradable Biosynthetic Material for Tissue Repair. Biomacromolecules, 3(4), 2002: 710-723.

12. B.L. Seal*, T. Otero*, and A. Panitch. Polymeric Biomaterials for Tissue and Organ Regeneration. Materials Science and Engineering R: Reports. 43(4-5), 2001: 147-230.

11. S. Sakiyama-Elbert, A. Panitch and J. A. Hubbell. Development of Growth Factor Fusion Proteins for Cell-Triggered Drug Delivery. FASEB J. 15(7), 2001: 1300-1302.

10. K. D. Zio, E. Welsh, A. Panitch, S. Heilshorn, P. Nowatski, D. Tirrell. New macromolecular architectures for control of cell and tissue behavior. Amer. Chem. Soc. 221, 2001: U146-U146.

9. S.I. Helms Tillery, P.J. Rousche, K. Hausmann, D. Hall, M. Beaumont, A. Panitch, D.R. Kipke. Nerve growth factor dependent changes in electrophysiology measured in a neurotrophic electrode. IEEE. 1, 2001: 741-744.

8. T. Tamura, T. Yamaoka, S. Kunki, A. Panitch and D. A. Tirrell. Effects of Temperature and Pressure on the Aggregational Properties of an Engineered Elastin Model Peptide in Aqueous Solution. Biomacromolecules. 1(4) 2000: 552-5.

7. S.Sakiyama-Elbert, A. Panitch, J. Hubbell. Development of novel growth factor fusion proteins with exogenous crosslinking substrates for cellularly triggered delivery. Annals of Biomedical Engineering. 28, 2000.

6. J. Williams, D. Pellinen, D. Pivin, M. Holecko, R. Vetter, P. Rousche, S. Massia, A. Panitch, D. Kipke. Hybrid neural implants with integrated bioactive capability. Annals of Biomedical Engineering. 28, 2000. 

5. S. Sakiyama-Elbert, A. Panitch, J.A. Hubbell. Development of novel growth factor fusion proteins with exogenous immobilization domains for cellularly controlled drug delivery. Proceedings of the International Symposium on Controlled Release of Bioactive Materials. 27, 2000: 970-971.

4. A. Panitch, D.A.Tirrell. Artificial Extracellular Matrix Proteins for Graft Design. RG Landes. 1, 1999: 577-581.

3. A. Panitch, T. Yamaoka, M. J. Fournier, T. L. Mason, D. A. Tirrell. Design and Biosynthesis of Elastin-Like Artificial Extracellular Matrix Proteins Containing Periodically Spaced Fibronectin CS5 Domains. Macromolecules. 32, 1999: 1701-1704.

2. A. Panitch, K. Matsuki, E. Cantor, S. J. Cooper, E. D. T. Atkins, M. J. Fournier, T. L. Mason and D. A. Tirrell.Poly(L-alanylglycine): ‘Multigram-Scale Biosynthesis, Chrystallization, and Structural Analysis of Chain-Folded Lamella’. Macromolecules. 30, 1997: 42-49.

1. A. Panitch, M. J. Fournier, T. L. Mason and D. A. Tirrell. Design and Assembly of Artificial Protein-Based Materials. Journal of Biological Chemistry. 18, 1994: 283.


15. J.E. Paderi, A. Panitch. Collagen-targeted nanoparticles. U.S. Patent App. No.: 14/884,646. 2016. 

14. A. Panitch, B. Seal. Cell-permeant peptide-based inhibitor of kinases. U.S. Patent No.: 9,327,008. 2016.

13. A. Panitch, J.C. Bernhard, J.E. Paderi, S. Sharma. Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use. U.S. Patent No.: 9,217,016. 2015.

12. A. Panitch, J.E. Paderi, S.Sharma, K.A. Stuart, N. Marie Vazquez-Portalatin. Extracellular matrix-binding synthetic peptidoglycans. U.S. Patent  No.: 9,200,039. 2015. 

11. J.E. Paderi, A. Panitch. Collagen-targeted nanoparticles. U.S. Patent No.: 9173919. 2015.

10. A. Panitch. Polypeptide for treating or preventing adhesions. U.S. Patent No.: 9034815. 2015.

9. A. Panitch, J.E. Paderi, K. Park, K. Stuart, S. Higbee. Collagen-binding synthetic peptidoglycans, preparation, and methods of use. U.S. Patent No.: 8,846,003. 2014.

8. J.E. Paderi, A. Panitch, K. Park, K. Stuart. Collagen-binding synthetic peptidoglycans for use in vascular intervention. U.S. Patent App. No.: 14/474,832. 2014.

7. C. Brophy, A. Panitch, C. Parmiter, E. Furnish, P. Komalavilas. Methods for promoting wound healing and/or reducing scar formation. U.S. Patent No.: 8,765,673. 2014.

6. A. Panitch, B. Seal, B. Ward. Kinase inhibitors and uses thereof. U.S. Patent No.: 8,741,849. 2014.

5. A. Panitch, B. Seal, B. Ward. Polypeptide inhibitors of HSP27 kinase and uses therefor. U.S. Patent No.: 8,536,303. 2013.

4. A. Panitch, B. Seal, J.L. Brugnano, R.L. Bartlett, S. Sharma, J. Mcmasters. Compositions and methods for delivery of kinase inhibiting peptides. U.S. Patent App. No.: 14/383,701. 2013. 

3. J.E. Paderi, A. Panitch, K. Park, K. Stuart. Collagen-binding synthetic peptidoglycans for use in vascular intervention. U.S. Patent App. No.: 13/806,438. 2011.

2. C. Lander, A. Panitch, C. Brophy, B. Seal. Methods for treating or preventing vascular graft failure. U.S. Patent App. No.: 13/700,087. 2011.

1. C. Brophy, P. Komalavilas, A. Panitch, B. Seal. Reagents and methods for smooth muscle therapies. U.S. Patent No.: 7,135,453. 2006.

Comments are closed.